Nanobiotix S.A. Gain Loss On Remeasurement Of Net Defined Benefit Liability Asset
Nanobiotix S.A. (NNBXF) reported Gain Loss On Remeasurement Of Net Defined Benefit Liability Asset of -EUR 19.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Income Statement › Other Income
ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset · last filed 2026-03-31
| Period end | Gain Loss On Remeasurement Of Net Defined Benefit Liability Asset 6 month | Gain Loss On Remeasurement Of Net Defined Benefit Liability Asset 12 month | Gain Loss On Remeasurement Of Net Defined Benefit Liability Asset 12 month as first filed |
|---|---|---|---|
| 2025-12-31 | -19.00K EUR 20-F · filed 2026-03-31 | ||
| 2024-12-31 | 33.00K EUR 20-F · filed 2026-03-31 | ||
| 2024-06-30 | 0.00 EUR 6-K · filed 2024-09-18 | ||
| 2023-12-31 | -22.00K EUR 20-F · filed 2025-04-02 | ||
| 2023-06-30 | 0.00 EUR 6-K · filed 2023-09-26 | ||
| 2022-12-31 | -126.00K EUR 20-F · filed 2024-04-24 | ||
| 2022-06-30 | -106.00K EUR 6-K · filed 2022-09-28 | ||
| 2021-12-31 | -182.00K EUR 20-F · filed 2024-04-24 | ||
| 2021-06-30 | 0.00 EUR 6-K · filed 2021-09-08 | ||
| 2020-12-31 | 4.00K EUR 20-F · filed 2023-04-24 | -4.00K EUR 20-F · filed 2021-04-07 | |
| 2019-12-31 | 88.00K EUR 20-F/A · filed 2021-04-08 |